Sciensus Pharma Services Ltd: UK Public Sector Contracts Won & Awards

Large organisationCompanies House: Private Limited CompanyBurton-on-TrentNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPXLC-2487-LQPHCompanies House02759609 ↗ · Active

Where they win
i

67 awards (66 for a named lot, 99%, 1 for a whole procedure with no lot named) · top CPV classes, shares of all 67 awards. An award may cover more than one class.

3360 Pharmaceutical products32 awards · 48% · 31 awards naming a lot + 1 whole-procedure awards
8510 Health services7 awards · 10% · awards naming a lot
8531 Social work services6 awards · 9% · awards naming a lot
8514 Miscellaneous health services4 awards · 6% · awards naming a lot
Attributable award value
i
£41mOn 37 of 68 award records; the five largest make 40%. Largest rows below.
Typical attributable award
i
£670k middle valuerobust · n=37

Where their buyers are
i

ITL1 region of the buyer office · known for 64 of 64 awarded procedures · each procedure counts once

Northern Ireland37 procedures · 58%
East Midlands8 procedures · 13%
Greater London5 procedures · 8%
Yorkshire and the Humber4 procedures · 6%
South East England4 procedures · 6%
West Midlands2 procedures · 3%
East of England2 procedures · 3%
South West England1 procedure · 2%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 3 notices name this supplier, covering 5 lots since 23 Oct 2025 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
3 of 5Lots on 3 notices: a place is won per lot.
Authorities bid for
i
3

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health87%(58 awards)
    58 of 67 awards are NHS & health (87%).
  • Type not classified10%(7 awards)
    7 of 67 awards are Type not classified (10%).
  • Education3%(2 awards)
    2 of 67 awards are Education (3%).
AuthorityProceduresShareAward recordsLast activity
Belfast Health & Social Care Trust2742.2%278 Sept 2026
Northern Health and Social Care Trust914.1%917 Aug 2026
Berkshire Healthcare NHS Foundation Trustframework/DPS on 346.3%414 Sept 2026
East Midlands Pharmacy Collaborativeframework/DPS on 446.3%430 Jun 2025
NHS Englandframework/DPS on 446.3%428 Mar 2024
University Hospitals of Derby and Burton NHS Foundation Trustframework/DPS on 334.7%519 Sept 2025
Leeds Teaching Hospitals NHS Trustframework/DPS on 234.7%329 Apr 2024
HealthTrust Europe LLP (HTE)framework/DPS on 111.6%615 Sept 2026

Share = of the 64 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

44 of 75 awards carry an end date, 10 estimated from the duration · not a retender forecast

ContractEndsPublished value
CERTOLIZUMAB PEGOL PRE-FILLED PENS and SYRINGES 200MG/1ML INJECTION (homecare)30 Nov 2026£1,300,000
Framework for the provision of a Low-Tech Dispense and Delivery Service28 Feb 2027Not published
Framework Agreement for the Provision of a Low-Tech Homecare Dispense and Delivery Service28 Feb 2027Not published
Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies30 Apr 2027£2,760,000 ceiling
Framework Agreement for the Provision of High-Tech Home Delivery service for Parenteral Systemic Anti- Cancer Therapies and Other Biologicals Including Immunotherapies30 Apr 2027Not published
D102 - Framework Agreement for the Provision of a Mid- Tech Homecare Service for the Dispensing and Home Delivery of Self-Injecting and Self-Infused Products (including Pharma Funded Schemes) and removal of waste30 Jun 2027Not published
Framework for the provision of a Mid-Tech Home Delivery Service30 Jun 2027Not published
Supply of Nonchemotherapy Compounded Monoclonal Antibodies23 Sept 2027 estimated£58,028
Framework for the supply of Ready to Administer Products30 Sept 2027£6,400,000 ceiling
Framework for the supply of Ready to Administer Products30 Sept 2027£6,400,000 ceiling

Soonest 10 of 17.

Recent awards

Latest 30 of 68 award records naming this supplier

Contracts Finder adds 7 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 34 of 75 awards, estimated from the published duration on 10 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.